Platinum Investment Management LTD Denali Therapeutics Inc. Transaction History

Platinum Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $114,843 - $148,230	4,370 Added 8.57%	55,341 $1.54 Million
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $859,466 - $1.11 Million	20,180 Added 65.54%	50,971 $2.27 Million
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $1.48 Million - $3.74 Million	-40,002 Reduced 56.51%	30,791 $2.58 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $1.01 Million - $1.98 Million	70,793 New	70,793 $1.24 Million

241

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.76B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.